[HTML][HTML] Complement, a target for therapy in inflammatory and degenerative diseases

BP Morgan, CL Harris - Nature reviews Drug discovery, 2015 - nature.com
The complement system is a key innate immune defence against infection and an important
driver of inflammation; however, these very properties can also cause harm. Inappropriate or …

Complement regulatory proteins

BP Morgan, AL Harris - 1999 - books.google.com
From small beginnings in the early 1970s, the study of complement regulatory proteins has
grown in the last decade to the point where it dominates the complement field. This growth …

Regulation of the complement membrane attack pathway

BP Morgan - Critical Reviews™ in Immunology, 1999 - dl.begellhouse.com
Complement activation, triggered through classic, alternative, or lectin pathways of activation,
leads to activation of a final common reaction sequence, the membrane attack pathway, in …

[HTML][HTML] C3 glomerulopathy: consensus report

…, PJ Lavin, N Medjeral-Thomas, BP Morgan… - Kidney international, 2013 - Elsevier
C3 glomerulopathy is a recently introduced pathological entity whose original definition was
glomerular pathology characterized by C3 accumulation with absent or scanty …

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

…, SM Morgan, HTC Chan, BP Morgan… - Blood, The Journal …, 2003 - ashpublications.org
Despite the clinical success of anti-CD20 monoclonal antibody (mAb) in the treatment of
lymphoma, there remains considerable uncertainty about its mechanism of action. Here we …

[HTML][HTML] Complement in the pathogenesis of Alzheimer's disease

BP Morgan - Seminars in immunopathology, 2018 - Springer
The emergence of complement as an important player in normal brain development and
pathological remodelling has come as a major surprise to most scientists working in …

Complement deficiency and disease

BP Morgan, MJ Walport - Immunology today, 1991 - cell.com
… Here, Paul Morgan and Mark Walport review current knowledge of hereditary complement
deficiencies in humans, emphasizing the importance of these'experiments of nature'in …

[HTML][HTML] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies …

…, C Licht, C Loirat, F Monfort, BP Morgan… - Kidney international, 2017 - Elsevier
In both atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G) complement
plays a primary role in disease pathogenesis. Herein we report the outcome of a 2015 …

Complement: central to innate immunity and bridging to adaptive responses

BP Morgan, KJ Marchbank, MP Longhi, CL Harris… - Immunology letters, 2005 - Elsevier
The complement system, a pillar of innate immunity, has belatedly become recognised as a
key modulator of adaptive immunity, acting to direct, modulate and modify the responses of …

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome

…, P Sánchez-Corral, BP Morgan… - Proceedings of the …, 2007 - National Acad Sciences
Hemolytic uremic syndrome (HUS) is an important cause of acute renal failure in children.
Mutations in one or more genes encoding complement-regulatory proteins have been …